LY3848575
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LY3848575, covering 2025-12-18 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy [Phase 2]